Please use this identifier to cite or link to this item: https://oar.tib.eu/jspui/handle/123456789/4743
Files in This Item:
File SizeFormat 
Raman spectroscopy-based identification of toxoid vaccine products.pdf1,56 MBAdobe PDFView/Open
Title: Raman spectroscopy-based identification of toxoid vaccine products
Authors: Silge, AnjaBocklitz, Thomas W.Becker, BjoernMatheis, WalterPopp, JürgenBekeredjian-Ding, Isabelle
Publishers Version: https://doi.org/10.1038/s41541-018-0088-y
Issue Date: 2018
Published in: NPJ Vaccines 3 (2018)
Publisher: Berlin : Nature Publishing
Abstract: Vaccines are complex biomedicines. Manufacturing is time consuming and requires a high level of quality control (QC) to guarantee consistent safety and potency. An increasing global demand has led to the need to reduce time and cost of manufacturing. The evolving concepts for QC and the upcoming threat of falsification of biomedicines define a new need for methods that allow the fast and reliable identification of vaccines. Raman spectroscopy is a non-destructive technology already established in QC of classical medicines. We hypothesized that Raman spectroscopy could be used for identification and differentiation of vaccine products. Raman maps obtained from air-dried samples of combination vaccines containing antigens from tetanus, diphtheria and pertussis (DTaP vaccines) were summarized to compile product-specific Raman signatures. Sources of technical variance were emphasized to evaluate the robustness and sensitivity in downstream data analysis. The data management approach corrects for spatial inhomogeneities in the dried sample while offering a proper representation of the original samples inherent chemical signature. Reproducibility of the identification was validated by a leave-one-replicate-out cross-validation. The results highlighted the high specificity and sensitivity of Raman measurements in identifying DTaP vaccine products. The results pave the way for further exploitation of the Raman technology for identification of vaccines in batch release and cases of suspected falsification.
Keywords: Vaccines; quality control; manufacturing
DDC: 610
License: CC BY 4.0 Unported
Link to License: https://creativecommons.org/licenses/by/4.0/
Appears in Collections:Ingenieurwissenschaften



This item is licensed under a Creative Commons License Creative Commons